B
Bill Birmingham
Managing Director and Head of Research at REX Financial (REX Shares), a CFA charterholder and former hedge fund equity research analyst
3
APPEARANCES
2
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
NOV 2
NOV 9
NOV 16
Oct 19, 2026
Beyond GLP-1s: Investing in the Peptide Boom
S
2:14speaker_0HOST
How are you looking at it? I mean, you know, you say right now is the time, but what's your expectations here as peptides are becoming a big part of the conversation? I mean, just over the summer, the FDA recommended for approval six additional peptides that aren't currently approved for treatment on the markets.
B
2:33Bill BirminghamGUEST
And just to take a step back to your original comment about insulin, insulin is the original peptide treatment.
B
2:47Bill BirminghamGUEST
But what was interesting about that is while it was the original therapy for people, it still requires self-injection.
B
2:55Bill BirminghamGUEST
So people were essentially administering their own medical procedures themselves using needles and vials.
S
6:23speaker_0HOST
So as you went to construct this how did you decide which names went in I mean I know we've got some of them on the side here and it's obviously the big ones that make some of the big headline GLP ones I was mentioning but as you look at some of the smaller companies, how did you decide who became a part of pep T.
CHIP ETF Targets the Next Phase of the AI Buildout
S
1:11speaker_0HOST
Tell me about this ETF, CHIP.
B
1:20Bill BirminghamGUEST
We work closely with our partner at VettaFi to, uh, craft an index that we thought would, um, really give investors exposure both to the, you know, central chipmaking themes, but also kind of on a weighted basis and on a global basis, uh, in a way that they normally can't get, um, or it would be very difficult to do on an individual, uh, stock basis.
B
1:41Bill BirminghamGUEST
So, um, it, it's about 55 global companies, um, scattered across the United States, Asia, and Europe.
B
1:47Bill BirminghamGUEST
Um, it exclusively focuses on chip, um, wafer equipment fa- uh, equipment manufacturers, so about 50% of the fund, uh, is, is put into those stocks, and then the other 25 is put into, uh, advanced packaging and 25% into metrology.
B
2:03Bill BirminghamGUEST
So, um, you know, we are trying to capture where, uh, both the growth and the advantage in the chipmaking equipment sector lies.
S
2:26speaker_0HOST
Tell me about that.
Regulation reform with SEC Commissioner Peirce 3/16/26
12:50
24:41

Dominic ChuHOST
Do you feel as though right now there is a runway for a certain type of crypto-focused products that will appeal more to the masses who are trying to get a little bit more exposure without having to feel like they're so idiosyncratic in a market that, let's be honest, most people don't know that much about?
B
13:10Bill BirminghamGUEST
I think that you put it right on the head in the sense that the early kind of iterations of crypto were very trader driven for people who really understood kind of the early phases of technology.
B
13:21Bill BirminghamGUEST
Obviously, it's worth mapping a little bit to say that Bitcoin being kind of the originator, drew a lot of attention, became a worldwide asset, has kind of set the stage for the overall asset class, and then you had kind of an explosion of tokens after that who have all been kind of working to prove their use case over time.
B
13:38Bill BirminghamGUEST
So what's an advisor to do, right? How are you going to sort through this giant kind of Darwinian environment of protocols that are all fighting for ways to get investor attention? And the way we look at it is we think that indexing is going to be the way to get advisors to take that baby step into getting their clients allocated because what it allows them to do is to essentially let that kind of Darwinian battle happen underneath the surface while still maintaining asset class level exposure to what we call kind of the fifth asset class.
B
14:10Bill BirminghamGUEST
So crypto is now following on equities, fixed income, real estate, commodities, and now it's established itself through a lot of various kind of wins over the last 15 years to be its own asset class and at that point it deserves an allocation but you should really try to match it to the top level and I think an index product is the way that you know will allow people to get that kind of just like it
10 MINS LATER

Dominic ChuHOST
How exactly has that AI narrative affected the way that crypto investors and crypto portfolios operate?
B
24:48Bill BirminghamGUEST
I think the AI narrative is going to be incredibly bullish for crypto assets over the long term, and here's the case why.